Little Green Pharma Ltd (ASX: LGP) Share Price and News

Dr Fong has over 36 years in leadership roles in private hospitals, the public health systems, management consulting, academia, health research, aged care and not for profit organisations. Neale is currently CEO of Bethesda Health Care and formerly was Director General of the West Australian Department of Health. Neale is also Chair of the Risk Committee.

Mr Caithness is a corporate finance executive and consultant in Australia and international markets. Angus has ASX experience as a Company Secretary for the IPO of Haranga Resources (ASX:HAR). Following these roles, Angus acted as CFO of Tavan Tolgoi, the owner of coking coal deposit looking at a US$10 billion dual listing in London and Hong Kong prior to the change in the Mongolian government. Angus was previously an Executive Director at Ernst & Young in London and Australia specialising in initial public offerings of large cap mining companies.

Mr Fenlon to the position of Independent Non-Executive Director. David has more than 30 years experience in the FMCG and Consumer Goods Sectors. He is currently the Chair of Elixinol Wellness (ASX: EXL) and a Nonexecutive Director of Quest for Life Foundation. Until recently, David was CEO of The Platform Alliance Group, prior to which he served as Group CEO and Managing Director of BWX Limited (ASX: BWX) and Managing Director (Australia and New Zealand) of Blackmores Limited (ASX: BKL). David has worked with retail brands in Australia and internationally, including in key positions with Tesco (Europe) and Safeway (UK). David also served on the Board of Directors for the Special Olympics from May 2017 until June 2019.

Ms Solomon was a founder of Little Green Pharma and has grown the company from a medicinal cannabis startup to an industry leading medicinal cannabis brand in Australia and overseas. Fleta has 20 years' experience in corporate and consumer health markets.

Mr Lynch-Bell is a corporate finance executive and consultant. His early Ernst & Young career was focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Michael also led Ernst & Young's UK IPO and Global Natural Resources transaction teams in the Transaction Advisory practice. He has been involved advising companies on fundraising, re organisations, transactions, corporate governance as well as IPOs. Michael is a former Chair of the Bureau and current member of UNECE's Expert Group on Resource Management, non-executive Chair of Serabi Gold plc (SRB.L), and Senior Independent Director and Remuneration Committee Chair of Gem Diamonds Limited (LSE:GEMD).

--

-

-

-